Guidelines and statements
Evidence-based
guidelines and statements
These guidelines and statements reflect the evidence-based positions and practices of the world’s most highly respected diabetes associations.
Guidelines and statements
2023 American Association of Clinical Endocrinology consensus statement: Comprehensive T2D management algorithm
AACE 2023
IPSAD clinical practice consensus guidelines 2022
ISPAD 2022
2018 Diabetes Canada clinical practice guidelines – Diabetes and driving
Diabetes Canada 2018
Hypoglycaemia classification consensus statement
as published in Diabetes Care
as published in Diabetologia
IHSG 2017
Standards of medical care in diabetes
ADA 2023
Global guideline for type 2 diabetes
IDF 2017
Diabetes self-management education and support in adults with type 2 diabetes: A consensus report
ADA/ADCES/ Academy of Nutrition and Dietetics/AAFP/AAAP/AANP/AphA 2020
Management of hyperglycemia in type 2 diabetes
ADA/EASD 2022
Diabetes and driving: position statement
ADA 2014
Hypoglycemia and diabetes
ADA/ES workgroup 2013
Hypoglycemia: clinical practice guideline
Diabetes Canada 2018
* AACE = American Association of Clinical Endocrinologists; AADE = American Association of Diabetes Educators; ACE = American College of Endocrinology; ADA = American Diabetes Association; AND = Academy of Nutrition and Dietetics; CDA = Canadian Diabetes Association; EASD = European Association for the Study of Diabetes; ES = Endocrine Society; IDF = International Diabetes Federation; IHSG = International Hypoglycaemia Study Group; ISPAD = International Society for Pediatric and Adolescent Diabetes